VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
about
Roles for oestrogen receptor β in adult brain functionTherapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderSignaling mechanisms regulating adult neural stem cells and neurogenesisThe molecular neurobiology of depressionAlzheimer's Disease and Hippocampal Adult Neurogenesis; Exploring Shared MechanismsEmerging Roles of BAI Adhesion-GPCRs in Synapse Development and PlasticityAdult neural stem cells: an endogenous tool to repair brain injury?Vascular endothelial growth factors (VEGFs) and strokeCell atrophy and loss in depression: reversal by antidepressant treatmentEpigenetics of the depressed brain: role of histone acetylation and methylationPersistent Angiogenesis in the Autism Brain: An Immunocytochemical Study of Postmortem Cortex, Brainstem and Cerebellum.Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all?Desvenlafaxine may accelerate neuronal maturation in the dentate gyri of adult male ratsThe Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition.Hippocampal angiogenesis and progenitor cell proliferation are increased with antidepressant use in major depression.Functional role of adult hippocampal neurogenesis as a therapeutic strategy for mental disordersDepression, antidepressants, and neurogenesis: a critical reappraisal.Post-weaning chronic social isolation produces profound behavioral dysregulation with decreases in prefrontal cortex synaptic-associated protein expression in female rats.Glycogen synthase kinase-3 in the etiology and treatment of mood disorders.Is glycogen synthase kinase-3 a central modulator in mood regulation?Induction of neuronal vascular endothelial growth factor expression by cAMP in the dentate gyrus of the hippocampus is required for antidepressant-like behaviorsPeripheral BDNF produces antidepressant-like effects in cellular and behavioral modelsEnriched environment treatment reverses depression-like behavior and restores reduced hippocampal neurogenesis and protein levels of brain-derived neurotrophic factor in mice lacking its expression through promoter IV.Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depressionHippocampal bone morphogenetic protein signaling mediates behavioral effects of antidepressant treatmentRoles of vascular endothelial growth factor in amyotrophic lateral sclerosis.From synapse to nucleus: novel targets for treating depression.Hippocampal neurogenesis and antidepressive therapy: shocking relations.Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects.Antidepressants and Cdk inhibitors: releasing the brake on neurogenesis?Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro.Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia.Genome-wide association study of alcohol dependence:significant findings in African- and European-Americans including novel risk loci.Antidepressant acts on astrocytes leading to an increase in the expression of neurotrophic/growth factors: differential regulation of FGF-2 by noradrenalineNeurobiological alterations induced by exercise and their impact on depressive disorders [corrected].Rapid antidepressant changes with sleep deprivation in major depressive disorder are associated with changes in vascular endothelial growth factor (VEGF): a pilot studyDetrimental role of prolonged sleep deprivation on adult neurogenesis.Stress, depression, and neuroplasticity: a convergence of mechanisms.Gene regulatory network analysis reveals differences in site-specific cell fate determination in mammalian brain.
P2860
Q24625569-C0EDB2B2-A6AA-42D5-A3B2-C6ECC341979AQ24626017-5F80DFED-8837-44F1-AB75-CBCDF7A74614Q24633503-706AD5E5-07FD-4D12-939F-9B3888903DA5Q24656261-6F33B416-E385-46AF-9D09-FC0042AED96FQ26747569-427936F8-1843-491C-8E77-14F467D7D586Q26765596-E5F41E3B-9B9E-4372-A80E-3BD98672F8FFQ26829074-2672F60F-3F67-4912-A4F7-BD7DFFBE7A37Q26853592-DE4EBF6E-0C05-4F3C-BF93-00B788E9DDDAQ27013609-F6190512-9ED8-4635-A9E3-519C30041706Q27015084-E5FB34C4-F35B-4874-9FFD-E5E269B1508BQ27316211-BBAC96C5-E942-4DDB-9F27-3C96FA44537AQ28080546-995CD2C8-602C-4E9D-A75F-5198223AA0CFQ28539344-08D28DB1-F2DE-4CFC-968B-2063C910E5B5Q30373328-92526C96-C355-4C32-8A14-ABA41494C988Q30448565-92DDF43F-9E9C-43E9-8515-171023FEAB9EQ30458969-4ABE0EC3-B908-46C3-BB5E-30A8B80CE195Q30460361-81BE752A-69C3-4E17-97CC-A06F57E8E943Q30464987-8C02B21B-6ABA-451E-9CB7-FEDDC1FB6533Q30474415-04CA3F3C-CA92-4C4C-ADB9-560338A00614Q30475816-026654B6-8013-4EB1-93F9-E386F0462721Q30492433-76427501-514C-4D9C-A978-9E3CF9649499Q30497021-3A5A4FB1-AFE4-478C-AE9C-BD3023B6C62CQ30511875-554BDD18-0002-4E66-8E70-FCDBF8B36394Q30521434-A35ED165-F454-4EC8-8920-A2014D4395AEQ30843800-AA1C6E32-E11C-48F8-94B2-E6FAA865195FQ33616384-4A3D93F0-0F69-49D7-9802-E1F17D01A5E8Q33653177-F70E947C-357F-4FBE-97BD-1FC489286172Q33748285-B98CB81A-0464-471D-8716-1787E1B3F4FEQ33874356-0C7701B6-4093-44DB-91C5-88F2A51BCCDAQ33887734-34F60F36-B5E0-470B-B08A-59E710D3400AQ33893155-514457C2-2E2B-4D74-838C-200B2050E23CQ33902992-74FEAAE5-9A7B-4C74-94FA-20DB70D34F3CQ33966168-566177A2-FC4C-4E75-90E6-EED18092AAB1Q34193319-424BA947-3F11-4E2E-905F-506DDD2916DAQ34507303-44E3C938-52C0-4A65-B23B-D0E820C9E8D3Q34517902-B017A7E5-46F9-4854-AF69-C7D2E6929026Q34630614-6FAF516F-5203-493F-B48F-A48D19A4E1C1Q34669586-47459683-59DE-4A06-A38A-76EF748AD5A8Q34686632-771682D7-51EF-43B6-B561-C909D2FB9B16Q34730038-64A18EB4-2626-4052-9F4E-DC8C8FF08BBF
P2860
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
description
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 2007
@ast
im März 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/03/13)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/03/13)
@nl
наукова стаття, опублікована в березні 2007
@uk
name
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
@ast
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
@en
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
@nl
type
label
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
@ast
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
@en
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
@nl
prefLabel
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
@ast
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
@en
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
@nl
P2860
P3181
P356
P1476
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
@en
P2093
Jennifer L. Warner-Schmidt
Ronald S. Duman
P2860
P304
P3181
P356
10.1073/PNAS.0610282104
P407
P577
2007-03-13T00:00:00Z